|
|
epidermis development
|
GO:0008544 |
187 |
0.947
|
Mouse |
|
|
skin development
|
GO:0043588 |
220 |
0.594
|
Mouse |
|
|
gland development
|
GO:0048732 |
330 |
0.427
|
Mouse |
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.355
|
Mouse |
|
|
hair follicle development
|
GO:0001942 |
85 |
0.300
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.286
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.274
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.237
|
Human Mouse |
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.231
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.218
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.195
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.189
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.187
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.184
|
Mouse |
|
|
cell adhesion
|
GO:0007155 |
329 |
0.180
|
Mouse |
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.178
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.172
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.165
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.159
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.151
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.148
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.142
|
Mouse |
|
|
keratinocyte development
|
GO:0003334 |
10 |
0.136
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.135
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.132
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.128
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.123
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.123
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.120
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.119
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.118
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.115
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.113
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.110
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.109
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.107
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.106
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.101
|
Worm |
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.099
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.097
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.096
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.096
|
|
|
|
protein citrullination
|
GO:0018101 |
2 |
0.093
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.093
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.092
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.092
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.091
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.090
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.090
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.086
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.086
|
|
|
|
citrulline biosynthetic process
|
GO:0019240 |
2 |
0.085
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.084
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.084
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.083
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.082
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.082
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.080
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.078
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.078
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.077
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.077
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.073
|
Mouse |
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.073
|
Worm |
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.072
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.070
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.070
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.070
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.068
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.067
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.067
|
Human Mouse |
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.066
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.065
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.064
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.063
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.063
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.062
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.061
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.060
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.060
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.059
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.059
|
|
|
|
natural killer cell proliferation
|
GO:0001787 |
3 |
0.059
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.059
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.059
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.058
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.058
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.058
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.057
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.057
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.057
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.056
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.056
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.056
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.055
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.055
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.055
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.055
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.054
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.053
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.053
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.053
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.053
|
Human Mouse |
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.053
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.052
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.051
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.051
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.051
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.051
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.050
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.050
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.049
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.049
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.049
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.048
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.048
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.048
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.048
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.047
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.047
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.047
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.047
|
Mouse |
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.047
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.047
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.046
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.046
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.046
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.046
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.045
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.045
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.045
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.045
|
|
|
|
nk t cell proliferation
|
GO:0001866 |
2 |
0.045
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.044
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.044
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.044
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.044
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.044
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.044
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.043
|
|
|
|
keratinization
|
GO:0031424 |
9 |
0.043
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.043
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.042
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.042
|
|
|
|
icosanoid biosynthetic process
|
GO:0046456 |
15 |
0.042
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.042
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.042
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.042
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.042
|
Worm |
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.042
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.042
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.042
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.041
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.041
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.041
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.041
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.041
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.040
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.040
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.040
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.040
|
|
|
|
epinephrine transport
|
GO:0048241 |
1 |
0.040
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.040
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.040
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.039
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.039
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.039
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.039
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.039
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.039
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.038
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.038
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.038
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.038
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.038
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.038
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.038
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.038
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.037
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.037
|
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.037
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.037
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.037
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.037
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.037
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.037
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.037
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.037
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.037
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.037
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.037
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.037
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.037
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.036
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.036
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.036
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.036
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.036
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.036
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.036
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.036
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.035
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.035
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.035
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.035
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.035
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.035
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.035
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.035
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.035
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.035
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.035
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.034
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.034
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.034
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.034
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.034
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.034
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.034
|
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.034
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.034
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.034
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.034
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.034
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.034
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.034
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.033
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.033
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.033
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.033
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.033
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.033
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.033
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.033
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.033
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.033
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.033
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.033
|
|
|
|
regulation of lymphocyte anergy
|
GO:0002911 |
4 |
0.032
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.032
|
|
|
|
positive regulation of rac gtpase activity
|
GO:0032855 |
14 |
0.032
|
|
|
|
nonribosomal peptide biosynthetic process
|
GO:0019184 |
5 |
0.032
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.032
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.032
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.032
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.032
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.032
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.032
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.032
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.032
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.032
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.031
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.031
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.031
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.031
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.031
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.031
|
|
|
|
alpha beta t cell proliferation
|
GO:0046633 |
21 |
0.031
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.031
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.031
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.031
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.030
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.030
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.030
|
Mouse |
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.030
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.030
|
|
|
|
mature natural killer cell chemotaxis
|
GO:0035782 |
1 |
0.030
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.030
|
|
|
|
epinephrine secretion
|
GO:0048242 |
1 |
0.030
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.030
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.030
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.030
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.030
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.030
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.029
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.029
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.029
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.029
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.029
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.029
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.029
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.028
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.028
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.028
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.028
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.028
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.028
|
|
|
|
detection of stimulus involved in sensory perception
|
GO:0050906 |
44 |
0.028
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.028
|
|
|
|
regulation of t cell anergy
|
GO:0002667 |
4 |
0.028
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.028
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.027
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.027
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.027
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.027
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.027
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.027
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.027
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.027
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.027
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.027
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.027
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.026
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.026
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.026
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.026
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.026
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.026
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.026
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.026
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.026
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.026
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.026
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.026
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.026
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.026
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.026
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.026
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.026
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.026
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.026
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.025
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.025
|
|
|
|
translation
|
GO:0006412 |
93 |
0.025
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.025
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.025
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.025
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.025
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.025
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.025
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.025
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.025
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.025
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.025
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.025
|
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.024
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.024
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.024
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.024
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.024
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.024
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.024
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.024
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.024
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.024
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.024
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.024
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.024
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.023
|
|
|
|
mammary gland epithelial cell proliferation
|
GO:0033598 |
24 |
0.023
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.023
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.023
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.023
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.023
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.023
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.023
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.023
|
|
|
|
cochlea development
|
GO:0090102 |
35 |
0.023
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.023
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.023
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.023
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.023
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.022
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.022
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.022
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.022
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.022
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.022
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.022
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.022
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.022
|
|
|
|
positive regulation of lymphocyte anergy
|
GO:0002913 |
4 |
0.022
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.022
|
Human |
|
|
protein targeting
|
GO:0006605 |
143 |
0.022
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.022
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.022
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.022
|
|
|
|
regulation of cd8 positive alpha beta t cell activation
|
GO:2001185 |
3 |
0.021
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.021
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.021
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.021
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.021
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.021
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.021
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.021
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.021
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.021
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.021
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.021
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.021
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.021
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.021
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.021
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.021
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.021
|
|
|
|
sodium ion export from cell
|
GO:0036376 |
1 |
0.020
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.020
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.020
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.020
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.020
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.020
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.020
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.020
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.020
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.020
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.020
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.020
|
|
|
|
negative regulation of antigen receptor mediated signaling pathway
|
GO:0050858 |
16 |
0.020
|
|
|
|
immunoglobulin production in mucosal tissue
|
GO:0002426 |
3 |
0.020
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.020
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.020
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.020
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.020
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.020
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.020
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.019
|
|
|
|
hepatocyte apoptotic process
|
GO:0097284 |
11 |
0.019
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.019
|
Worm |
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.019
|
|
|
|
lipoprotein biosynthetic process
|
GO:0042158 |
33 |
0.019
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.019
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.019
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
51 |
0.019
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.019
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.019
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.019
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.019
|
Worm |
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.019
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.019
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.019
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.019
|
|
|
|
positive regulation of hair follicle development
|
GO:0051798 |
6 |
0.019
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.018
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.018
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.018
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.018
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.018
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.018
|
|
|
|
renal water homeostasis
|
GO:0003091 |
7 |
0.018
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.018
|
|
|
|
t helper 17 cell lineage commitment
|
GO:0072540 |
4 |
0.018
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.018
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.018
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.018
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.018
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.018
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.018
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.018
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.018
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.018
|
|
|
|
hyperosmotic response
|
GO:0006972 |
4 |
0.018
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.018
|
|
|
|
positive regulation of urine volume
|
GO:0035810 |
6 |
0.018
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.018
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.018
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.018
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.017
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.017
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.017
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.017
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.017
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.017
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.017
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.017
|
|
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
3 |
0.017
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.017
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.017
|
|
|
|
skeletal muscle tissue regeneration
|
GO:0043403 |
20 |
0.017
|
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.017
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.017
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.017
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.017
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.017
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.017
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.017
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.017
|
|
|
|
regulation of actin filament bundle assembly
|
GO:0032231 |
18 |
0.017
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.017
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.017
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.017
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.017
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.016
|
Worm |
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.016
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.016
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.016
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.016
|
Human |
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.016
|
|
|
|
lymphocyte anergy
|
GO:0002249 |
4 |
0.016
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.016
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.016
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.016
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.016
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.016
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.016
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.016
|
|
|
|
otic placode formation
|
GO:0043049 |
1 |
0.016
|
|
